WallStreetZenWallStreetZen

NASDAQ: PRVA
Privia Health Group Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Privia Health Group earnings were $18.2M for the trailing 12 months ending Sep 30, 2025, with 25% growth year over year. The latest PRVA earnings report on Sep 30, 2025 announced Q3 2025 earnings of $6.9M, up 155.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRVA reported annual earnings of $14.4M, with -37.7% growth. The next PRVA earnings date is Mar 3, 2026.

PRVA past earnings growth

How has PRVA's earnings growth performed historically?

Company
25%
Industry
23.37%
Market
56.32%
PRVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PRVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PRVA's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PRVA earnings history

Current Revenue
$2.0B
Current Earnings
$18.2M
Current Profit Margin
0.9%

PRVA Return on Equity

Current Company
2.7%
Current Industry
7.2%
Current Market
35.1%
PRVA's Return on Equity (2.7%)... subscribe to Premium to read more.
High Return on Equity Performance

PRVA Return on Assets

Current Company
1.5%
Current Industry
5.1%
PRVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PRVA announces earnings.

PRVA Return on Capital Employed

Current Company
4.2%
Current Industry
7.6%
PRVA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRVA vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PRVA$41.33M$18.17M-32.58%$0.15
WGS$29.13M$2.08M-99.22%$0.11
TXG-$30.81M-$76.32MN/A-$0.63
HNGEN/AN/AN/AN/A
HTFLN/AN/AN/AN/A
View Top Health Information Service Stocks

PRVA earnings dates

Next earnings date
Mar 3, 2026

Privia Health Group Earnings Reports & History FAQ

What were Privia Health Group's earnings last quarter?

On PRVA's earnings call on Invalid Date, Privia Health Group (NASDAQ: PRVA) reported Q3 2025 earnings per share (EPS) of $0.06, up 100% year over year. Total PRVA earnings for the quarter were $6.86 million. In the same quarter last year, Privia Health Group's earnings per share (EPS) was $0.03.

If you're new to stock investing, here's how to buy Privia Health Group stock.

When does Privia Health Group report earnings?

The next PRVA earnings call is Invalid Date. Add PRVA to your watchlist to be reminded of Privia Health Group's next earnings date.

Is Privia Health Group profitable or losing money?

As of the last Privia Health Group earnings report, Privia Health Group is currently profitable. Privia Health Group's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $18.17 million, a 41.66% increase year over year.

What was PRVA's earnings growth in the past year?

As of Privia Health Group's earnings date in Invalid Date, Privia Health Group's earnings has grown 25% year over year. This is 1.63 percentage points higher than the US Health Information Services industry earnings growth rate of 23.37%. PRVA earnings in the past year totalled $18.17 million.

What are Privia Health Group's earnings expectations?

The current EPS estimate for Privia Health Group's earnings report in Invalid Date is $0.04.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.